1. Adaway JE, Keevil BG, Owen LJ. Liquid chromatography tandem mass spectrometry in the clinical laboratory. Ann Clin Biochem. 2015; 52:18–38.
Article
2. Antonelli G, Marinova M, Artusi C, Plebani M. Mass spectrometry or immunoassay: est modus in rebus. Clin Chem Lab Med. 2017; 55:1243–5.
Article
3. Hoofnagle AN and Wener MH. The fundamental faws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009; 347:3–11.
4. Kim B, Lee MN, Park HD, Kim JW, Chang YS, Park WS, et al. Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population. Ann Lab Med. 2015; 35:578–85.
Article
5. Han M, Jun SH, Song SH, Park KU, Kim JQ, Song J. Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population. Korean J Lab Med. 2011; 31:250–6.
Article
6. Yu S, Kang ES, Park MH. A questionnaire survey of HLA crossmatch tests in Korea (2015). Lab Med Online. 2017; 7:147–56.
Article
7. Kim CK, Lee H, Yong D, Kim YA. National survey on biosafety in clinical tuberculosis laboratories in Korea. Lab Med Online. 2017; 7:189–95.
Article
8. Lee S, Yu GG, Park KH, Lee SY, Jekarl DW, Yoon NS, et al. Survey of fungal cultures and the identifcation tests used by diagnostic laboratories in Korea. J Lab Med Qual Assur. 2016; 38:143–50.
9. Koh YR, Kim SY, Kim IS, Chang CL, Lee EY, Son HC, et al. Customer satisfaction survey with clinical laboratory and phlebotomy services at a tertiary care unit level. Ann Lab Med. 2014; 34:380–5.
Article
10. de Denus S, Letarte N, Hurlimann T, Lambert JP, Lavoie A, Robb L, et al. An evaluation of pharmacists'expectations towards pharmacogenomics. Pharmacogenomics. 2013; 14:165–75.
11. Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar. J Eval Clin Pract. 2015; 21:703–9.
Article